Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure

NARecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Heart Failure Preserved Ejection Fraction
Interventions
DEVICE

Coronary Sinus Reducer

Subjects will have the Coronary Sinus Reducer implanted in their coronary sinus during a right heart catheterization procedure.

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Shockwave Medical, Inc.

INDUSTRY

lead

Mayo Clinic

OTHER